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ABSTRACT 
The present research work describes a simple, accurate, precise, effective, stability indicating, RP-HPLC method for estimation of Etizolam in 
there tablet dosage form. A Reverse phase high performance chromatographic method was developed for estimation of Etizolam dosage. The 
separation was achieved by Cosmosil C18 (250mm×4.6ID, Particle size: 5 micron) and methanol: water in the proportion of 30:70v/v as mobile 
phase, at a flow rate 0.8ml/min. Detection was carried out at 242nm. For RP-HPLC method results of the validation indicate that the method 
was linear in the range of 100-600 µg/ml for Etizolam. The % recoveries for Etizolam obtained in the accuracy study were 99.77-99.51% 
respectively. The LOD for Etizolam were found to be 0.7877µg/ml. LOQ for Etizolam found to be 2.382µ/ml. Developed methods were found to 
be accurate, precise, rapid and stability indicating for estimation of Etizolam. 
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1. INTRODUCTION 
1.1 Drug Profile  
Etizolam (ETI) belongs to an original chemical class of 
diazepines, namely thienotriazolodiazepines with 
antianxiety activity and chemically  it is 4-(2-
chlorophenyl)-2-ethyl-9-methyl-6H-thieno [3,2-f] [1,2,4] 
triazolo -[4,3-a] [1,4]diazepines 1)[1,2]. ECS is official in 
IP’10 and ETI is official in JP XV [3,4]. 
Literature survey also reports few HPLC [5] methods for 
estimation of Etizolam (ETI) individually or in combination 
with other drugs. Present work describes rapid, simple, 
sensitive, accurate and reproducible stability indicating 
method. 
Structure : 
 
 
IUPAC Name : 4-(2-chlorophenyl)-2-ethyl-9-
methyl-6H-thieno[3,2-
f][1,2,4triazolo[4,3-
a][1,4]diazepine. 
Molecular 
Formula: 
C17H15ClN4S [8] 
Molecular 
weight: 
342.854 g/mol 
Appearance : White powder 
Melting Point : 145-148℃ 
Boiling Point : 545.3±60 
Category : Amnesic, anxiolytic, 
anticonvulsant, hypnotic, 
sedative and skeletal muscle 
relaxant.[6] 
Solubility :  No soluble in water. Soluble in 
acid water and in polyethylene 
glycol and ethanol. 
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Mechanism of Action  
Etizolam is selectively a full agonist at GABA receptor to 
increase GABAergic transmission and enhance GABA-
induced Cl-currents[11]. It is reported to bind to the 
benzodiazepine binding site which is located across the 
interface between the alpha and gamma subunits [12]. 
The present study aimed to develop a simple, sensitive, 
short retention time and accurate, validation of RP-HPLC 
method for estimation of Etizolam in bulk and tablet 
dosage form. 
2. MATERIALS AND METHOD : 
Etizolam is gift sampled by Macleods Pharmaceutical Ltd., 
Daman, Gujarat.  
All solvents and other reagents were of HPLC grade. 
2.1. Instruments and Apparatus: 
 System used for the research : HPLC Binary Gradient 
system 
 Model no. : HPLC 3000 Series (Analytical 
Technologies Ltd.) 
 Column : Cosmosil C18 (250mm×4.6ID, Particle size: 
5 micron) 
     2.2. Preparation of Standard Solution - 
 Preparation of std stock solution of Etizolam – 
(1000ppm) 
Weighed accurately 10mg of pure drug and dissolved in 
10ml of solvent (Methanol: water (50:50); this gives 
1000ppm solution of Etizolam. From this 0.1ml was 
transferred to 10 ml volumetric flask to prepare solution of 
100 ppm.  
2.3. Selection of Wavelength for Estimation: 
Standard solution of Etizolam of concentration 10µg/ml 
was scanned between 200-400 nm using methanol as 
blank. The peak was obtained at 248nm. 
 
Fig : 1.Spectra of standard  Etizolam for wavelength 
selection. 
2.4 Trial batches for selecting optimum solvent system 
Trial batches were run as per following chromatographic 
conditions by using methanol and water in the ratio of 
90:10, 80:20 and 70:30 respectively. 
Table 1: optimized chromatographic condition 
Parameters Condition 
Stationary Phase Cosmosil C18 
(250mm×4.6ID, Particle 
size: 5 micron) 
Mobile Phase Methanol : water  
Pump Mode Reciprocating 
Flow Rate (ml/min) 0.8ml/min 
Run Rate (min) 9.79 
Volume of Injection 
(microliter) 
20 
Detection Wavelength 248 
Retention time (min) 7.003 
 
 
Table 2: System suitability parameters for final optimized chromatographic conditions 
Parameters Data Obtained 
 70 : 30 80 : 20 
Retention Time (Rt) 7.003 min 4.345 min 
Resolution 0.00 0.00 
Theoretical Plates (N) 3827 8695 
Tailing Factor (Tf) 1.44 1.15 
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--------------------------------------------------------- 
Fig2. Chromatogram of standard showing separated peak of Etizolam. 
 
From above findings, it was concluded that the most efficient 
resolution and peak symmetry for Etizolam achieved with 
the above chromatographic conditions and with a mobile 
phase composed of Methanol: water (70:30%v/v) 
3. METHOD VALIDATION  
The described method has been validated for linearity, 
accuracy, limit of detection, limit of quantification, and 
robustness, as per ICH guidelines. 
3.1 Linearity  
Linear relation was obtained between mean peak area and 
concentration of the drug in the range of 10-50µg/ml. The 
data of peak areas obtained with the respective 
concentration in microgram/ml are shown in Table 3 for 
Etizolam. The linearity curves for Etizolam shown in Fig 3. 
Table 3: Data of peak area of Etizolam (10-50µg/ml) 
Sr. No. Concentration (µg/ml) Peak area of Etizolam 
1 10 601683 
2 20 1253654 
3 30 1865239 
4 40 2415986 
5 50 3093992 
 
 
Fig 3: Calibration Curve for Etizolam. 
3.2 Accuracy  
Accuracy refers to closeness of the test results obtained by 
the method to the true value. Accuracy was performed by 
the standard addition methods. To a fixed amount of the pre-
analysed mixture add a 50%, 100%, and 150% of the 
standard solution and % recovery was calculated. The 
results are shown in table 4. 
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Table 4: Recovery data for Etizolam 
Sr. No % Composition Area of Standard Area of Sample % Recovery 
     
1 50% Recovery 1865239 1861110 99.77863427 
     
2 100% Recovery 2415986 2399110 99.30148602 
     
3 150% Recovery 3093992 3078990 99.5151248 
     
 
3.3. Precision  
3.3.1 Repeatability –  
It was performed by 100% test concentration level and % RSD was calculated. The data for repeatability for Etizolam is 
presented in table no. 5 
Table 5 : Repeatability data for Etizolam 
   Standard Deviation Accuracy Precision 
Sr. No Conc. Area Mean SD %SD %RSD 
 10 601683     
1 10 605015 603668.6667 1755.59572 0.2908211 0.290821077 
 10 604308     
       
 30 1865239     
2 30 1861683 1865816 449.647065 0.2384826 0.2848263 
 30 1870526     
       
 50 3093992     
3 50 3080256 3090886.667 9467.967329 0.3063188 0.306318812 
 50 3098412     
       
 
3.3.2 Reproducibility –  
In that the data for Interday and Intraday precision for 
Etizolam was performed. It was performed by 100% test 
concentration level and % RSD was calculated. 
A: Interday Precision of Etizolam - 
The data for Interday precision for Etizolam are present in 
table 6. For Interday sample solution containing 100 µg/ml 
were prepared six times and measured on the different days 
and % RSD was calculated. The % RSD for Interday precision 
for Etizolam was found to be 0.33%. 
 
Table 6: Interday Precision - 
Sr. No Day 1 Day 2 Mean % RSD 
     
1 1865239 1855353   
     
2 1861683 1860249 1871110 0.33% 
     
3 1870526 1871110   
     
 
B: Intraday Precision of Etizolam - 
The data for Intraday precision for Etizolam shown in table 
7. For Intraday sample solution of 100 µg/ml of Etizolam 
were prepared six times and measured on the same day and 
% RSD was calculated. The % RSD for Intraday precision was 
found to be 0.23%. 
 
Table 7: Intraday Precision - 
Sr. No Morning Evening Mean % RSD 
     
1 1865239 1870976   
     
2 1861683 1867709 1868304 0.23% 
     
3 1870526 1873693   
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3.4 Limit of Detection (LOD) and Limit of Quantification 
(LOQ) : 
3.4.1: Limit of detection (LOD) – 
Limit of detection is calculated by using formula, 
LOD = 3.3× (SD/Slope) 
LOD = 3.3× (0.2384/0.999) 
LOD = 0.7875µg/ml. 
3.4.2: Limit of Quantification (LOQ) –  
Limit of Quantification is calculated by using formula, 
LOQ = 10× (SD/Slope) 
LOQ = 10× (0.2384/0.999) 
LOQ = 2.3863 µg/ml. 
3.5: Robustness  
Robustness was calculated by using two methods, i.e; change 
in flow rate and change in wavelength. 
3.5.1: The data for Robustness of Etizolam for change in flow 
rate is shown in table no.8. 
 
Table 8: Robustness data for change in flow rate – 
Sr. No Conc. Area Mean SD %SD 
 20 1250874    
1. 20 1253654 1251021 2562.18 0.20480698 
 20 1248536    
 
3.5.2: The data for Robustness of Etizolam for change in wavelength is shown in table no.9. 
Table 9: Robustness data for change in wavelength – 
Sr. No Conc. Area Mean SD %SD 
 20 1253654    
1. 20 1251683 1253657 1975 0.15753925 
 20 1255633    
 
3.6: Ruggedness  
The data for Ruggedness of Etizolam is shown in table no. 10 
Table 10: Data for Ruggedness of Etizolam – 
Sr. No Concentration Area 
   
1 10 605246 
2 20 1255624 
3 30 1868954 
4 40 2420158 
5 50 3095487 
 
The Ruggedness curve for Etizolam is shown in Fig. 4. 
 
 
Fig 4. Ruggedness curve for Etizolam. 
3.7: Assay  
By using the standard areas from linearity of reported concentration the % assay was calculated. 
The data for assay of Etizolam is shown in table no. 11 
y = 61450x + 5589 
R² = 0.9991 
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Table 11: Data for assay of Etizolam – 
Sr. No % Composition Area of Standard Area of Sample % Assay 
     
1. % Assay 1865239 1865239 100 
     
 
4. RESULTS AND DISCUSSION 
4.1. Optimized chromatographic conditions  
The optimized chromatographic conditions fig 1.The best 
peak shape and maximum separation was achieved with 
mobile phase Methanol : Water in the proportion of 70:30 
%v/v, peak symmetry and reproducibility obtained on 
Cosmosil C18 (250mm*4.6ID, Particle size : 5 micron), 
optimum wavelength. For detecting analyte, ƛmax was found 
to be 248nm, A flow rate of 0.8ml/min yielded optimum 
separation and peak symmetry. Chromatogram of Etizolam 
fig 2 and optimized chromatographic condition is shown in 
table 1. 
4.2. Linearity  
Linear relation was obtained between mean peak area and 
concentration of the drug in the range of 10-50µg/ml for 
Etizolam. Shown in fig.3 
4.3. Accuracy  
The percentage recovery for Etizolam were 99.77–99.51%, 
shown in table 4 and 5 
4.4. Precision  
4.4.1. Interday – 
The data for Interday precision for Etizolam is present in 
table.6.  The % RSD for Interday was found to be 0.33%. 
4.4.2. Intraday – 
The data for Intraday precision for Etizolam is present in 
table.7.  The % RSD for Intraday was found to be 0.23%. 
4.5. LOD and LOQ  
The LOD for Etizolam were found to be 0.7875µg/ml.  
LOQ for Etizolam were found to be 2.3863µg/ml.  
4.6. Robustness  
Result of the Robustness table no. 8. The %SD for Robustness 
for change in flow rate was found to be 0.2048%. Shown in 
table no.8. 
The % SD for Robustness for change in wavelength was 
found to be 0.1575%. Shown in table no. 9. 
 
4.7. Ruggedness  
The result for Ruggedness curve for Etizolam is shown in fig. 
4. 
5. CONCLUSION  
A simple, fast, accurate and precise RP-HPLC analytical 
method has been developed and validated for the 
Quantitative analysis of Etizolam in Bulk form. The results of 
stress testing undertake according to the ICH guidelines 
reveal that the method is specific and accurate. 
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